Last December, the company raised its quarterly payout for the 16th consecutive year. The dividend yield investors could ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...

Natural gas futures rise on heat-driven demand. Traders await today’s storage report and watch $3.301 resistance for bullish ...

Markets today face key jobs data, fresh U.S. tariffs, and earnings from Wendy’s, AMC Networks, and other midcaps ahead of the ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

Yet, within the past 24 hours, Trump has doubled the tariffs on India to 50%, imposed an additional 15% on Japan, announced a ...

Eli Lilly & Co. tumbled in early trading as disappointing data on its new weight-loss pill overshadowed strong growth from the company’s current obesity medicine that helped drive it to raise its ...

AstraZeneca, which last week announced a $50bn plan for US development, declined to comment. Pfizer, Abbvie, and Germany’s ...

New data highlights an unprecedented crisis in National Health Service patient waiting lists and sheds light on how the ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...